EUVIMEDEUVIMED entdecken
Crossref

Characterization of Pediatric Patch Testing: A Retrospective Review, 2020–2023

Caroline Brumley iD, Puneet Arora iD, Sara A Hylwa

Dermatitis® · 2024

DOI: 10.1089/derm.2024.0005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Dermatitis®, 2024. Verfasst von Caroline Brumley und 2 weiteren Autor:innen. Beteiligte Einrichtung: From the Department of Dermatology, Park Nicollet Health Services, Minneapolis, Minnesota, USA. Hauptthemen laut MEDLINE: Patch Tests, Dermatitis, Allergic Contact, Allergens. Die Arbeit nennt 19 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Recent evidence shows similar rates of allergic contact Dermatitis® (ACD) among children and adults despite children accounting for less than 10% of patch testing subjects. With a need for in-depth analyses of pediatric ACD, we herein characterize a pediatric cohort at a large North American patch testing center.

Methods

A retrospective chart review was conducted for 135 patients ages 1–17 years who underwent patch testing from July 2020 from August 2023. Data were stratified by age 1–5, 6–11, and 12–17 years. Significance-Prevalence Index Numbers (SPIN) were calculated.

Results

A total of 86% were sensitized, 40% had a relevant reaction, and positivity rates were equal between males and females. Top allergens by SPIN differed with age, but overall were linalool hydroperoxides (SPIN = 11.01), propylene glycol (10.30), limonene hydroperoxides (10.27), fragrance mix I (5.62), and lanolin (4.90). In total, 14% of the top allergens were not represented on the North American Contact Dermatitis® Group standard series. Of those tested to personal products, 45% had positive reactions and 72% of which were relevant.

Conclusions

Emulsifiers and fragrances were the most relevant allergen categories, with the impact of emulsifiers not previously reported. ACD may affect males and females equally in this population. Supplemental allergens and personal products tested “as-is” contribute to conclusive pediatric patch testing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Patch TestsDermatitis, Allergic ContactAllergensHumansChildRetrospective StudiesFemaleMaleChild, PreschoolAdolescentInfantPerfumeLanolinAcyclic MonoterpenesLimonenePropylene GlycolPrevalence

Substanzen

AllergensPerfumelinaloolLanolinAcyclic MonoterpenesLimonenePropylene Glycol

Autor:innen und Institutionen

  • From the Department of Dermatology, Park Nicollet Health Services, Minneapolis, Minnesota, USA.
  • University of Minnesota Medical School, Minneapolis, Minnesota, USA.
  • Department of Dermatology, Hennepin Healthcare, Minneapolis, Minnesota, USA.
  • Department of Dermatology, University of Minnesota, Minneapolis, Minnesota, USA.

ORCID-Profile: Caroline Brumley, Puneet Arora

Zitieren

APA

Brumley, C., Arora, P., & Hylwa, S. A. (2024). Characterization of Pediatric Patch Testing: A Retrospective Review, 2020–2023. Dermatitis®. https://doi.org/10.1089/derm.2024.0005

Vancouver

Brumley C, Arora P, Hylwa SA. Characterization of Pediatric Patch Testing: A Retrospective Review, 2020–2023. Dermatitis®. 2024. doi:10.1089/derm.2024.0005

BibTeX
@article{Brumley2024,
  author = {Brumley, Caroline and Arora, Puneet and Hylwa, Sara A},
  title = {Characterization of Pediatric Patch Testing: A Retrospective Review, 2020–2023},
  journal = {Dermatitis®},
  year = {2024},
  doi = {10.1089/derm.2024.0005}
}
Kostenlos starten →